Malaria chemoprophylaxis with tafenoquine: a randomised study (Q28140217)

2

0 references

M A Missinou

3

0 references

S Borrmann

4

0 references

O Dangelmaier

5

0 references

J Horton

6

0 references

P G Kremsner

Malaria control in Nicaragua: social and political influences on disease transmission and control activities

7

0 references

language of work or name

English

0 references

publication date

10 June 2000

0 references

published in

The Lancet

0 references

volume

355

0 references

page(s)

2041-5

0 references

issue

9220

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902352-7

7 January 2021

Epidemic of malaria in north-eastern Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902352-7

7 January 2021

The distribution of birth weights in Gambian women who received malaria chemoprophylaxis during their first pregnancy and in control women.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902352-7

7 January 2021

The presentation, management and prevention of crisis in sickle cell disease in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902352-7

7 January 2021

Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902352-7

7 January 2021

Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902352-7

7 January 2021

Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902352-7

7 January 2021

Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902352-7

7 January 2021

Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902352-7

7 January 2021

Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902352-7

7 January 2021

Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902352-7

7 January 2021

The role of red blood cell polymorphisms in resistance and susceptibility to malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902352-7

7 January 2021

Confidence limits on the ratio of two Poisson variables

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902352-7

7 January 2021

First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902352-7

7 January 2021

10.1016/S0140-6736(00)02352-7

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

4387318

4387318

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference